Vismia guianensis
Vismia guianensis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Vismia guianensis is a versatile plant species recognized for its significant bioactive properties, particularly within its leaves. The plant contains specialized chemical compounds such as anthraquinones, physcion, and vismiaquinone A. Researchers have utilized various preparations, including essential oils, extracts, and hexane leaf extracts, to study its medicinal potential. Scientific investigations have explored its efficacy against conditions like Leishmania infection, rheumatism, and fever. Additionally, its biological activity has shown promise in addressing the growth of C. parapsilosis.
- Synonyms
- Caopia Acuminata · Caopia Guianensis · 20 more
- Common names
- Not available
- Family
- Hypericaceae
- Distribution
- Southern America
- Plant Parts
- Leaf
Classification
Common Names
Vismia guianensis is a botanical species known by several distinct common names depending on the local region. It is frequently referred to as the Black Kiskadee or simply the Kiskadee in various parts of its range. In the specific context of Trinidad and Tobago, the plant is widely recognized by the name La Craie. These diverse names highlight the plant's cultural and linguistic presence across different geographical landscapes. Understanding these variations helps researchers and locals alike identify the species more effectively.
Sources: Catalogue of Life (COL)
Synonyms
Vismia guianensis is a botanical species characterized by a complex history of taxonomic synonyms. Within scientific literature, this plant has been identified under various names, including Caopia acuminata and Caopia guianensis. It is also frequently referred to by the synonym Caopia reichardtiana in certain collections. Furthermore, taxonomic classifications have linked the species to the names Hypericum acuminatum and Hypericum cuspidatum. Understanding these diverse designations is essential for accurate identification and consistent botanical study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Vismia guianensis is a distinct biological entity belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It is further organized into the order Malpighiales, showcasing its specific evolutionary lineage. This plant is a proud member of the genus Vismia, which defines its close botanical relatives. Finally, its taxonomic placement is completed by its membership in the family Hypericaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Hypericaceae |
| Genus | Vismia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Vismia guianensis is a widespread species with a significant presence throughout South America. It is particularly abundant across the vast landscapes of Brazil, spanning from the North and Northeast to the Southeast and West-Central regions. Beyond the South American continent, its natural range extends into the Caribbean. Specifically, the plant can be found growing within the islands of Trinidad and Tobago. This broad distribution highlights the plant's ability to thrive in diverse tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Vismia guianensis is a self-supporting plant that takes the form of a tree. This species typically reaches a moderate height, generally staying within a range of 6 to 10 meters. Its sturdy structure allows it to stand firmly within its natural habitat. Ultimately, this growth pattern defines its presence in the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Vismia guianensis is a medicinal plant native to the Amazon rainforest that has traditionally been used to treat fever, rheumatism, and wounds. Chemical analysis of its hexane leaf extract reveals that the plant is particularly rich in anthraquinones. Specifically, researchers have identified vismiaquinone A as one of the major components found within the species. Additionally, the presence of physcion has been confirmed through thin-layer chromatography and NMR analysis. Understanding these specific chemical constituents is essential for evaluating the plant's safety and potential therapeutic applications.
Conditions
Vismia guianensis essential oils exhibit significant antifungal activity against several pathogenic strains. Specifically, the oil from this plant species effectively treats C. albicans and C. glabrata. It also demonstrates the ability to treat C. krusei and C. parapsilosis. Furthermore, the medicinal properties of Vismia guianensis extend to the treatment of C. tropicalis. These results highlight the potential of the plant for managing various forms of candidiasis.
Preparations
Vismia guianensis is prepared as essential oils through hydrodistillation to evaluate its antifungal activity against various Candida species. The plant is also prepared as extracts, which have demonstrated significant lethal activity against MCF-7 human breast adenocarcinoma cell lines. Furthermore, Vismia guianensis is prepared as a hexane leaf extract to study its toxicological properties using the Caenorhabditis elegans model. This specific hexane extract is characterized by being rich in anthraquinones such as vismiaquinone A and physcion. Together, these various preparation methods allow for the exploration of the plant's medicinal and biological potential.
Parts used
Vismia guianensis is a medicinal plant native to the Amazon rainforest that has long been used to treat ailments such as fever and rheumatism. Scientific interest in this species has focused heavily on its leaves, which serve as a rich source of bioactive compounds. Research involving hexane leaf extracts has identified key components like vismiaquinone A and physcion, which are vital for understanding its toxicological profile. Additionally, the essential oils derived from the leaves have demonstrated significant antifungal activity against various Candida species. Together, these studies highlight the therapeutic potential of the plant's foliage in developing new clinical treatments.